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GFRa-4 and the tyrosine kinase Ret form a functional receptor
complex for persephin
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Arnon Rosenthal§, Vladimir L. Buchman* and Alun M. Davies*
Glial-cell-line-derived neurotrophic factor (GDNF) [1],
neurturin [2] and persephin [3] are structurally related,
secreted proteins that are widely expressed in the
nervous system and other tissues [1–5] and promote
the survival of a variety of neurons during development
[1–12]. GDNF and neurturin signal through
multicomponent receptors that consist of the Ret
receptor tyrosine kinase and one of two structurally
related glycosyl-phosphatidylinositol (GPI)-linked
ligand-binding subunits: GFRa-1 is the preferred ligand-
binding subunit for GDNF, and GFRa-2 is the preferred
ligand-binding subunit for neurturin [13–21]. Two
additional members of the GFRa family of GPI-linked
proteins have recently been cloned: GFRa-3 [21–23] and
GFRa-4 [24]. We have shown that persephin binds
efficiently only to GFRa-4, and labelled persephin is
effectively displaced from cells expressing GFRa-4 by
persephin but not by GDNF or neurturin. Using
microinjection to introduce expression plasmids into
cultured neurons, we have also shown that
coexpression of Ret with GFRa-4 confers a marked
survival response to persephin but not to GDNF or
neurturin. These results demonstrate that GFRa-4 is the
ligand-binding subunit for persephin and that
persephin, like GDNF and neurturin, also requires Ret
for signalling.
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Results and discussion
Binding of persephin to GFRa-4
To determine whether persephin binds to GFRα-4 or
other members of the GFRα family, microtitre plates were
coated with immunoglobulin G (IgG)-tagged versions of
the four GFRα receptors and incubated with
[125I]persephin with or without cold competitor. As shown
in Figure 1, [125I]persephin exhibited clear displaceable
binding to GFRα-4–IgG. In contrast, no significant
binding of [125I]persephin to GFRα-1–IgG, GFRα-2–IgG
or GFRα-3–IgG could be detected. As expected from the
results of previous studies [13,14,17,18], GDNF and neur-
turin showed specific, displaceable binding to IgG-tagged
GFRα-1 and GFRα-2, respectively (data not shown).
These results demonstrate that among the GFRα family
only GFRα-4 is a ligand-binding subunit for persephin. 
To further characterise GFRα-4, we analysed human
embryonic 293 kidney cells that were transiently trans-
fected with full-length GFRα-4. Whereas low concentra-
tions of unlabelled persephin very effectively displaced
[125I]persephin from GFRα-4-expressing cells, GDNF
Figure 1
Bar chart of the amount of [125I]persephin bound to microtitre 
plates coated with rat GFRα-1–IgG, human GFRα-2–IgG, human 
GFRα-3–IgG and chicken GFRα-4–IgG in the presence (non-specific
binding) or absence (total binding) of excess of unlabelled mouse
persephin. The means and standard errors of a typical experiment are
shown. Abbreviation: cpm, counts per minute.
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and neurturin at concentrations up to 10 µM were ineffec-
tive in displacing [125I]persephin (Figure 2). In experi-
ments with much higher concentrations (50 µM) of
GDNF and neurturin, some displacement of
[125I]persephin was reproducibly observed (data not
shown). Persephin did not show displaceable binding to
untransfected 293 cells (data not shown). These results
indicate that GFRα-4 is a ligand-binding subunit for
persephin. Scatchard analysis of the displacement data
gave a dissociation constant (Kd) of approximately 1 nM,
which is higher than the previously reported Kd of GDNF
and neurturin binding to GFRα-1 and GFRα-2, respec-
tively [13,17,21]. Although this may reflect true differ-
ences in the affinity of GDNF, neurturin and persephin
for their respective GPI-linked ligand-binding subunits,
the difference in the Kd estimations may be due in part to
differences in protein stability, persephin being the more
labile protein. Alternatively, the lower affinity of
persephin for GFRα-4 may reflect the fact that we studied
the binding of mouse persephin to chicken GFRα-4.
Expression of Ret and GFRa-4 on neurons confers a
survival response to persephin 
To ascertain the potential involvement of GFRα-4 in
mediating the survival responses of neurons to members
of the GDNF family of neurotrophic factors, we used
microinjection to introduce an expression plasmid contain-
ing GFRα-4 cDNA into cultured superior cervical sympa-
thetic ganglion (SCG) neurons from postnatal day 4 (P4)
mice because the survival of these neurons is not 
promoted by neurturin, GDNF or persephin in culture
([18] and data not shown). 
Figure 3 shows that ectopic expression of GFRα-4 alone
in SCG neurons has a negligible effect on the survival of
postnatal SCG neurons and does not confer a survival
response to persephin. This is consistent with the idea
that GPI-linked receptors cannot mediate responses to
their ligands without the appropriate transmembrane sig-
nalling proteins such as Ret in the case of GFRα-1 and
GFRα-2 [13,17–19,21], and gp130 and the leukemia
inhibitory factor receptor β (LIFRβ) in the case of the
ciliary neurotrophic receptor α (CNTFRα) [25].
Because Ret is essential for GDNF and neurturin signalling
[13–21,26,27], we coinjected neurons with expression plas-
mids for Ret and GFRα-4 to see whether neurons express-
ing both of these receptor components would exhibit
survival responses to GDNF, neurturin or persephin. Con-
firming previous findings [18], ectopic expression of Ret
alone promoted the survival of approximately 15% of SCG
neurons in the absence of added factors (Figure 3). This is
explained by the finding that Ret is, to a certain extent,
constitutively phosphorylated on tyrosine when overex-
pressed in cells in the absence of ligand [21]. 
Persephin did not increase the survival of Ret-express-
ing neurons, indicating (as with GDNF and neurturin in
the same experimental paradigm [18]) that Ret alone is
not capable of mediating a survival response to
persephin. Neurons coexpressing Ret plus GFRα-4 had
a substantially enhanced survival response to persephin,
however; the number of neurons coexpressing GFRα-4
plus Ret that survived with persephin was 2.5-fold
higher than the number of such neurons grown without
this factor (Figure 3). 
In contrast, neurons coexpressing Ret plus GFRα-4
showed no enhanced survival response to GDNF. As a
positive control, we showed that neurons coexpressing
Ret plus GFRα-1 had an enhanced survival response to
GDNF, similar to that reported previously [18]. Neurons
coexpressing Ret plus GFRα-4 showed a small increase in
survival in the presence of neurturin; however, this
response was much less than the response of GFRα-4
plus Ret coexpressing neurons to persephin, or the
response of GFRα-2 plus Ret coexpressing neurons to
neurturin (Figure 3). Although GFRα-1 and GFRα-2 in
the presence of Ret conferred survival responses to
GDNF and neurturin, respectively, neurons coexpressing
Ret with either GFRα-1 or GFRα-2 did not exhibit a sur-
vival response to persephin (data not shown). Our results
therefore indicate that GFRα-4 is a ligand-binding
subunit for persephin and that Ret is required for sig-
nalling and the survival response of GFRα-4-expressing
neurons to persephin.
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Figure 2
Graph of displacement binding of [125I]persephin by rat GDNF, human
neurturin and mouse persephin from GFRα-4 expressed on human
embryonic 293 kidney cells. A value of 100% corresponds to the
amount of [125I]persephin bound in the absence of cold ligand. One
representative experiment out of four is shown.
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The above results were obtained using ligands at a con-
centration of 5 ng/ml. GFRα-1 and GFRα-2 were previ-
ously shown to mediate specific survival responses to
5 ng/ml GDNF and neurturin, respectively [18].
However, 50 ng/ml GDNF was found to promote the sur-
vival of GFRα-2 plus Ret coexpressing neurons as effec-
tively as neurturin, although 50 ng/ml neurturin did not
enhance the survival of GFRα-1 plus Ret coexpressing
neurons [18]. In our present studies, 50 ng/ml neurturin
promoted a further small increase in the survival of
neurons coexpressing GFRα-4 and Ret compared with
the number supported by 5 ng/ml, although the level of
this response was still less than the response to persephin
of neurons coexpressing GFRα-4 and Ret, or the
response to neurturin of neurons coexpressing GFRα-2
and Ret (Figure 3). Although 50 ng/ml GDNF promoted
a small increase in the survival of neurons coexpressing
GFRα-4 and Ret compared with neurons coexpressing
GFRα-4 and Ret but grown without this factor (Figure
3), this increase was not statistically significant (p > 0.05, t
test). Taken together, these receptor reconstitution
experiments in cultured neurons indicate that the
Ret–GFRα-4 receptor complex is very effective at medi-
ating responses to persephin and is capable of mediating
modest responses to high concentrations of neurturin.
These responses to different concentrations of persephin
and neurturin may reflect physiologically relevant differ-
ences in the signalling specificity of the Ret–GFRα-4
receptor complex at different ligand concentrations
in vivo. 
In summary, we have shown that GFRα-4 is a ligand-
binding subunit for persephin and that persephin addi-
tionally requires Ret for signal transduction. Our findings
extend the generality of the notion that members of the
GDNF family of secreted proteins exert their actions by a
receptor complex that consists of a common receptor tyro-
sine kinase and a member of a GPI-linked family that
confers ligand specificity. The preferred GPI-linked
receptors for GDNF, neurturin and persephin are 
GFRα-1, GFRα-2 and GFRα-4, respectively, and all
require Ret for signal transduction. There is evidence,
however, that at high concentrations, GDNF and neur-
turin can bind to both GFRα-1 and GFRα-2 and activate
Ret [18–22], and we have provided some evidence that
high concentrations of neurturin can promote the survival
of neurons coexpressing Ret and GFRα-4, although not as
effectively as much lower concentrations of persephin.
These results suggest a degree of receptor–ligand
crosstalk among the GFRα family that may be physiologi-
cally relevant. In this respect it is interesting that recent
studies of GFRα-1–/– mice suggest that the importance of
GFRα-1 in mediating responses to GDNF and neurturin
differs among certain populations of neurons [28]. The
demonstration that the three most closely related
members of the GFRα family, GFRα-1, GFRα-2 and
GFRα-4, are ligand-binding subunits for GDNF, neur-
turin and persephin raises the issue of the identity of the
ligand for GFRα-3. Given our present findings, it seems
likely that a fourth, possibly more distantly related
member of the GDNF family remains to be identified.
Materials and methods
Binding of persephin to GFRα–IgG-linked receptors
GFRα–IgG-tagged receptors were made by transfecting 293 human
embryonic kidney cells by the calcium phosphate method with an
expression construct consisting of a cDNA encoding the respective
GFRα receptor without its GPI-linked consensus sequence fused in-
frame with a cDNA encoding the Fc region of human IgG1 [29]. The
recombinant GFRα–IgG fusion proteins were purified on a protein
A–sepharose column (Pharmacia) and quantified by a human Fc-spe-
cific ELISA.
Plates (96 well) were coated with a goat anti-human antibody overnight
after which the recombinant GFRα–IgG fusion proteins were captured
at 1 µg/ml for 1 h. Binding reactions were then performed in PBS with
0.1% BSA and 0.05% Tween20 in the presence of 20 pM
[125I]persephin with (non-specific binding) or without (total binding)
excess unlabelled persephin (0.1 mg/ml) for 2 h at room temperature.
The plates were washed three times with PBS 0.05% Tween and each
well was counted for 1 min.
Competition binding
Competition binding of [125I]persephin to GFRα-4 was carried out on
human embryonic 293 kidney cells transiently transfected with an
expression plasmid encoding full-length chicken GFRα-4 under the
control of a CMV promoter. After overnight transfection by the CaPO4
method the cells were allowed to recover for 24 h. Binding was then
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Figure 3
Bar chart of the percentage of survival of P4 mouse SCG neurons
48 h after injection with expression plasmids for GFRα-1, GFRα-2,
GFRα-4 or Ret alone or in the indicated combinations. The injected
neurons were incubated in medium containing GDNF, neurturin (NTN)
or persephin (PSP) at a concentration of 5 ng/ml. The means and
standard errors of the combined results of nine separate experiments
are shown (n ≥ 6 for each experimental condition).
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performed in PBS containing 0.1% BSA with 2 million cells in a volume
of 250 µl overnight at 4°C. Reactions were spun down, resuspended in
100 µl ice cold PBS and layered on a 250 µl cushion of PBS contain-
ing 0.1% BSA and 20% sucrose and centrifuged at 10000 rpm for
1 min. The cell pellet was counted in an Isodata-100 gamma counter.
Neuronal culture and microinjection studies
To investigate the ability of GFRα-4 and Ret to mediate the survival
responses of neurons to GDNF, neurturin and persephin, microinjec-
tion was used to introduce expression plasmids (GFRα-1 cDNA,
GFRα-2 cDNA, GFRα-4 cDNA and c-ret cDNA in pMEX) into P4
mouse SCG neurons. Purified P4 SCG neurons were grown in serum-
free medium on a poly-ornithine/laminin substratum. The neurons were
initially grown for 12 h with NGF (2 ng/ml) and were washed exten-
sively to remove the NGF just before being injected with expression
plasmids into the nucleus [18]. The cultures were supplemented with
either GDNF, neurturin or persephin immediately after injection and the
number of surviving neurons was counted at this time and 48 h later. 
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